FMR1 and fragile X syndrome: These researchers used the Fmr1 knockout FXS mouse model (Bakker et al., 1994; Mientjes et al., 2006; Dahlhaus, 2018) to evaluate the effect of blarcamesine on key cognitive and behavioral aspects that represent the FXS phenotype.